Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,160 | N/A |
| Depreciation Amortization | 148 | N/A |
| Accounts receivable | 202 | N/A |
| Other Working Capital | -649 | N/A |
| Other Operating Activity | 1,291 | 0 |
| Operating Cash Flow | $-1,168 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -5 | N/A |
| Other Investing Activity | 11 | 0 |
| Investing Cash Flow | $6 | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 12,566 | N/A |
| Common Stock Issued | -500 | N/A |
| Other Financing Activity | -10,807 | 0 |
| Financing Cash Flow | $1,259 | $N/A |
| Beginning Cash Position | 112 | N/A |
| End Cash Position | 209 | N/A |
| Net Cash Flow | $97 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -1,168 | N/A |
| Capital Expenditure | -5 | N/A |
| Free Cash Flow | -1,173 | 0 |